Resmed Revenue vs. Cash Per Share

RMEA Stock  EUR 21.60  0.20  0.92%   
Based on the measurements of profitability obtained from Resmed's financial statements, Resmed Inc DRC may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Resmed's ability to earn profits and add value for shareholders.
For Resmed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Resmed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Resmed Inc DRC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Resmed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Resmed Inc DRC over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center.
Please note, there is a significant difference between Resmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Resmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Resmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Resmed Inc DRC Cash Per Share vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Resmed's current stock value. Our valuation model uses many indicators to compare Resmed value to that of its competitors to determine the firm's financial worth.
Resmed Inc DRC is currently regarded number one company in revenue category among its peers. It also is currently regarded as top stock in cash per share category among its peers . The ratio of Revenue to Cash Per Share for Resmed Inc DRC is about  35,781,270,000 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Resmed's earnings, one of the primary drivers of an investment's value.

Resmed Revenue vs. Competition

Resmed Inc DRC is currently regarded number one company in revenue category among its peers. Market size based on revenue of Medical Instruments & Supplies industry is at this time estimated at about 18.54 Billion. Resmed retains roughly 3.58 Billion in revenue claiming about 19% of all equities under Medical Instruments & Supplies industry.

Resmed Cash Per Share vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Resmed

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
3.58 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Resmed

Cash Per Share

 = 

Total Cash

Average Shares

 = 
0.10 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

Resmed Cash Per Share Comparison

Resmed is currently under evaluation in cash per share category among its peers.

Resmed Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Resmed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Resmed will eventually generate negative long term returns. The profitability progress is the general direction of Resmed's change in net profit over the period of time. It can combine multiple indicators of Resmed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California. RESMED CUFS10 is traded on Frankfurt Stock Exchange in Germany.

Resmed Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Resmed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Resmed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Resmed's important profitability drivers and their relationship over time.

Use Resmed in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Resmed position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Resmed will appreciate offsetting losses from the drop in the long position's value.

Resmed Pair Trading

Resmed Inc DRC Pair Trading Analysis

The ability to find closely correlated positions to Resmed could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Resmed when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Resmed - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Resmed Inc DRC to buy it.
The correlation of Resmed is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Resmed moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Resmed Inc DRC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Resmed can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Resmed position

In addition to having Resmed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Toys Thematic Idea Now

Toys
Toys Theme
Companies producing and distributing toys and different gaming products for kids. The Toys theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Toys Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Resmed Stock

To fully project Resmed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Resmed Inc DRC at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Resmed's income statement, its balance sheet, and the statement of cash flows.
Potential Resmed investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Resmed investors may work on each financial statement separately, they are all related. The changes in Resmed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Resmed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.